Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


31.07.2017

1 Acta Psychiatr Scand
3 Am J Psychiatry
2 Biol Psychiatry
1 Br J Psychiatry
2 Can J Psychiatry
1 Cortex
1 Int J Geriatr Psychiatry
1 Neuropsychopharmacology
1 Psychiatry Res
3 Psychol Med
9 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Psychiatr Scand

  1. KIM JS, Park CM, Choi JA, Park E, et al
    The association between season of birth, age at onset, and clozapine use in schizophrenia.
    Acta Psychiatr Scand. 2017 Jul 25. doi: 10.1111/acps.12776.
    PubMed     Text format     Abstract available


    Am J Psychiatry

  2. DAVIDSON M, Saoud J, Staner C, Noel N, et al
    Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.
    Am J Psychiatry. 2017 Jul 28:appiajp201717010122.
    PubMed     Text format     Abstract available

  3. BASSETT AS, Lowther C, Merico D, Costain G, et al
    Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome.
    Am J Psychiatry. 2017 Jul 28:appiajp201716121417.
    PubMed     Text format     Abstract available

  4. WIMBERLEY T, MacCabe JH, Laursen TM, Sorensen HJ, et al
    Mortality and Self-Harm in Association With Clozapine in Treatment-Resistant Schizophrenia.
    Am J Psychiatry. 2017 Jul 28:appiajp201716091097.
    PubMed     Text format     Abstract available


    Biol Psychiatry

  5. HARTZ SM, Horton AC, Oehlert M, Carey CE, et al
    Association Between Substance Use Disorder and Polygenic Liability to Schizophrenia.
    Biol Psychiatry. 2017 Jun 6. pii: S0006-3223(17)31624.
    PubMed     Text format     Abstract available

  6. COLLIN G, Scholtens LH, Kahn RS, Hillegers MHJ, et al
    Affected Anatomical Rich Club and Structural-Functional Coupling in Young Offspring of Schizophrenia and Bipolar Disorder Patients.
    Biol Psychiatry. 2017 Jun 21. pii: S0006-3223(17)31712.
    PubMed     Text format     Abstract available


    Br J Psychiatry

  7. TOMASSI S, Tosato S, Mondelli V, Faravelli C, et al
    Influence of childhood trauma on diagnosis and substance use in first-episode psychosis.
    Br J Psychiatry. 2017 Jul 20. pii: bjp.bp.116.194019.
    PubMed     Text format     Abstract available


    Can J Psychiatry

  8. ADDINGTON J, Addington D, Abidi S, Raedler T, et al
    CPA Treatment Guidelines for Individuals at Clinical High Risk of Psychosis.
    Can J Psychiatry. 2017 Jan 1:706743717719895. doi: 10.1177/0706743717719895.
    PubMed     Text format     Abstract available

  9. ADDINGTON D, Abidi S, Garcia-Ortega I, Honer WG, et al
    Guidelines for the Assessment and Diagnosis of Patients with Schizophrenia Spectrum and Other Psychotic Disorders.
    Can J Psychiatry. 2017 Jan 1:706743717719899. doi: 10.1177/0706743717719899.
    PubMed     Text format     Abstract available


    Cortex

  10. STEPHAN-OTTO C, Siddi S, Senior C, Cuevas-Esteban J, et al
    Remembering verbally-presented items as pictures: Brain activity underlying visual mental images in schizophrenia patients with visual hallucinations.
    Cortex. 2017;94:113-122.
    PubMed     Text format     Abstract available


    Int J Geriatr Psychiatry

  11. MCLACHLAN E, Bousfield J, Howard R, Reeves S, et al
    Reduced parahippocampal volume and psychosis symptoms in Alzheimer's disease.
    Int J Geriatr Psychiatry. 2017 Jul 25. doi: 10.1002/gps.4757.
    PubMed     Text format     Abstract available


    Neuropsychopharmacology

  12. BRUCATO G, Appelbaum PS, Lieberman JA, Wall MM, et al
    A Longitudinal Study of Violent Behavior in a Psychosis-Risk Cohort.
    Neuropsychopharmacology. 2017 Jul 26. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


    Psychiatry Res

  13. HILL K, Bolo N, Sarvode Mothi S, Lizano P, et al
    Subcortical surface shape in youth at familial high risk for schizophrenia.
    Psychiatry Res. 2017;267:36-44.
    PubMed     Text format     Abstract available


    Psychol Med

  14. RUS-CALAFELL M, Garety P, Sason E, Craig TJK, et al
    Virtual reality in the assessment and treatment of psychosis: a systematic review of its utility, acceptability and effectiveness.
    Psychol Med. 2017 Jul 24:1-30. doi: 10.1017/S0033291717001945.
    PubMed     Text format     Abstract available

  15. MOLLON J, Reichenberg A
    Cognitive development prior to onset of psychosis.
    Psychol Med. 2017 Jul 24:1-12. doi: 10.1017/S0033291717001970.
    PubMed     Text format     Abstract available

  16. DREIER JW, Berg-Beckhoff G, Andersen AMN, Susser E, et al
    Fever and infections during pregnancy and psychosis-like experiences in the offspring at age 11. A prospective study within the Danish National Birth Cohort.
    Psychol Med. 2017 Jul 24:1-11. doi: 10.1017/S0033291717001805.
    PubMed     Text format     Abstract available


    Schizophr Res

  17. FARGOTSTEIN M, Hasenkamp W, Gross R, Cuthbert B, et al
    The effect of antipsychotic medications on acoustic startle latency in schizophrenia.
    Schizophr Res. 2017 Jul 18. pii: S0920-9964(17)30432.
    PubMed     Text format     Abstract available

  18. MORITZ S, Bentall RP, Kolbeck K, Roesch-Ely D, et al
    Monocausal attribution and its relationship with reasoning biases in schizophrenia.
    Schizophr Res. 2017 Jul 18. pii: S0920-9964(17)30396.
    PubMed     Text format     Abstract available

  19. PILLAI A, Schooler NR, Peter D, Looney SW, et al
    Predicting relapse in schizophrenia: Is BDNF a plausible biological marker?
    Schizophr Res. 2017 Jul 19. pii: S0920-9964(17)30398.
    PubMed     Text format     Abstract available

  20. FUSAR-POLI P, Palombini E, Davies C, Oliver D, et al
    Why transition risk to psychosis is not declining at the OASIS ultra high risk service: The hidden role of stable pretest risk enrichment.
    Schizophr Res. 2017 Jul 19. pii: S0920-9964(17)30353.
    PubMed     Text format     Abstract available

  21. GANELLA EP, Seguin C, Bartholomeusz CF, Whittle S, et al
    Risk and resilience brain networks in treatment-resistant schizophrenia.
    Schizophr Res. 2017 Jul 20. pii: S0920-9964(17)30415.
    PubMed     Text format     Abstract available

  22. EBISCH SJH, Gallese V, Salone A, Martinotti G, et al
    Disrupted relationship between "resting state" connectivity and task-evoked activity during social perception in schizophrenia.
    Schizophr Res. 2017 Jul 20. pii: S0920-9964(17)30421.
    PubMed     Text format     Abstract available

  23. WANG HY, Guo WJ, Li XJ, Tao YJ, et al
    Higher required dosage of antipsychotics to relieve the symptoms of first-onset Acute and Transient Psychotic Disorder (ATPD) predicted the subsequent diagnostic transition to schizophrenia: A longitudinal study.
    Schizophr Res. 2017 Jul 21. pii: S0920-9964(17)30412.
    PubMed     Text format    

  24. CHIU PW, Lui SSY, Hung KSY, Chan RCK, et al
    In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study.
    Schizophr Res. 2017 Jul 24. pii: S0920-9964(17)30422.
    PubMed     Text format     Abstract available

  25. ZULIANI R, Delvecchio G, Bonivento C, Cattarinussi G, et al
    Increased gyrification in schizophrenia and non affective first episode of psychosis.
    Schizophr Res. 2017 Jul 17. pii: S0920-9964(17)30399.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: